Immediate Impact
7 from Science/Nature 59 standout
Citing Papers
Engineered commensals for targeted nose-to-brain drug delivery
2025 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Ann Polonskaia being referenced
Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN
2019
Iberdomide (CC-220) Has Synergistic Anti-Tumor and Immunostimulatory Activity Against Multiple Myeloma in Combination with Both Bortezomib and Dexamethasone, or in Combination with Daratumumab in Vitro
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ann Polonskaia | 320 | 135 | 113 | 10 | 433 | |
| Lukas Orel | 249 | 30 | 64 | 15 | 425 | |
| Luisa Caione | 180 | 61 | 66 | 8 | 438 | |
| Kate F. Whitecross | 289 | 34 | 93 | 6 | 373 | |
| Hans L. P. van Duijnhoven | 269 | 38 | 99 | 10 | 504 | |
| Terry A. Woodford | 351 | 19 | 62 | 8 | 451 | |
| Judith L. Scott | 127 | 58 | 47 | 9 | 386 | |
| Hélène Favre | 205 | 49 | 241 | 10 | 498 | |
| T W Dolby | 258 | 73 | 57 | 10 | 476 | |
| Kerrie Wilson | 145 | 140 | 118 | 10 | 468 | |
| Satoshi Yoshimura | 178 | 29 | 73 | 13 | 376 |
All Works
Loading papers...